First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
Bristol-Myers Squibb
Paul Baas; Arnaud Scherpereel; Anna K Nowak; Nobukazu Fujimoto; Solange Peters; Anne S Tsao; Aaron S Mansfield; Sanjay Popat; Thierry Jahan; Scott Antonia; Youssef Oulkhouir; Yolanda Bautista; Robin Cornelissen; Laurent Greillier; Francesco Grossi; Dariusz Kowalski; Jerónimo Rodríguez-Cid; Praveen Aanur; Abderrahim Oukessou; Christine Baudelet; Gérard Zalcman